Invesco
SPPI

Invesco’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Invesco’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-58,745
Closed -$76K – 4192
2022
Q1 		$76K Sell
58,745
-852,164
-94% -$785K ﹤0.01% 3889
2021
Q4 		$1.16M Buy
910,909
+14,434
+2% +$25.8K ﹤0.01% 3001
2021
Q3 		$1.96M Buy
896,475
+6,133
+0.7% +$16.8K ﹤0.01% 2823
2021
Q2 		$3.34M Buy
890,342
+67,786
+8% +$236K ﹤0.01% 2621
2021
Q1 		$2.68M Sell
822,556
-51,958
-6% -$186K ﹤0.01% 2655
2020
Q4 		$2.98M Buy
874,514
+19,780
+2% +$81.4K ﹤0.01% 2443
2020
Q3 		$3.49M Buy
854,734
+129,558
+18% +$493K ﹤0.01% 2189
2020
Q2 		$2.45M Sell
725,176
-7,949
-1% -$23.2K ﹤0.01% 2381
2020
Q1 		$1.71M Buy
733,125
+73,908
+11% +$202K ﹤0.01% 2485
2019
Q4 		$2.4M Sell
659,217
-10,486
-2% -$84.7K ﹤0.01% 2571
2019
Q3 		$5.55M Sell
669,703
-71,795
-10% -$581K ﹤0.01% 2071
2019
Q2 		$6.38M Sell
741,498
-259,096
-26% -$2.32M ﹤0.01% 2032
2019
Q1 		$10.7M Sell
1,000,594
-93,887
-9% -$1.01M ﹤0.01% 1531
2018
Q4 		$9.58M Sell
1,094,481
-265,760
-20% -$3.39M ﹤0.01% 1556
2018
Q3 		$22.9M Buy
1,360,241
+607,833
+81% +$13.2M 0.01% 1201
2018
Q2 		$15.8M Sell
752,408
-470,118
-38% -$8.71M 0.01% 1377
2018
Q1 		$19.7M Buy
1,222,526
+484,054
+66% +$9.59M 0.01% 1175
2017
Q4 		$14M Buy
738,472
+345,013
+88% +$6.25M 0.01% 1398
2017
Q3 		$5.54M Buy
393,459
+158,354
+67% +$1.43M ﹤0.01% 1905
2017
Q2 		$1.75M Buy
235,105
+15,882
+7% +$104K ﹤0.01% 2663
2017
Q1 		$1.43M Buy
219,223
+4,556
+2% +$25.5K ﹤0.01% 2832
2016
Q4 		$951K Sell
214,667
-485,225
-69% -$2.04M ﹤0.01% 3012
2016
Q3 		$3.27M Buy
699,892
+32,524
+5% +$193K ﹤0.01% 2253
2016
Q2 		$4.38M Buy
667,368
+316,368
+90% +$2.24M ﹤0.01% 2012
2016
Q1 		$2.23M Buy
351,000
+109,608
+45% +$562K ﹤0.01% 2395
2015
Q4 		$1.46M Buy
241,392
+15,133
+7% +$86.5K ﹤0.01% 2733
2015
Q3 		$1.35M Buy
226,259
+32,122
+17% +$223K ﹤0.01% 2753
2015
Q2 		$1.33M Buy
194,137
+21,912
+13% +$139K ﹤0.01% 2909
2015
Q1 		$1.04M Buy
172,225
+24,513
+17% +$163K ﹤0.01% 3014
2014
Q4 		$1.02M Sell
147,712
-6,862
-4% -$50.5K ﹤0.01% 2959
2014
Q3 		$1.26M Buy
154,574
+4,736
+3% +$37.1K ﹤0.01% 2831
2014
Q2 		$1.22M Sell
149,838
-24,478
-14% -$186K ﹤0.01% 2898
2014
Q1 		$1.37M Buy
174,316
+30,547
+21% +$259K ﹤0.01% 2833
2013
Q4 		$1.27M Buy
143,769
+10,231
+8% +$91.4K ﹤0.01% 2957
2013
Q3 		$1.12M Sell
133,538
-1,803,076
-93% -$14.6M ﹤0.01% 2948
2013
Q2 		$14.4M Buy
+1,936,614
New +$14.9M 0.01% 1244

Other funds holding SPPI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Invesco's SPPI Position: Q2 2022 in Review

Invesco sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q2 2022, closing a stake of 58,745 shares — an estimated $76K sold.

Invesco first reported a position in SPPI in Q2 2013 and held it in 36 quarters. The position peaked at $22.9M in Q3 2018. 86 funds tracked by Wall St. Rank hold SPPI as of Q2 2022.

  • Invesco reported no remaining Spectrum Pharmaceuticals Inc position as of Q2 2022 after selling out during the quarter.
  • Invesco sold 58,745 Spectrum Pharmaceuticals Inc shares in Q2 2022, an estimated $76K.
  • Invesco first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 36 quarters.
  • Invesco's Spectrum Pharmaceuticals Inc position peaked at $22.9M in Q3 2018.
  • 86 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q2 2022.

Based on Invesco's 13F filing for Q2 2022, filed 15 Aug 2022.